Virus vaccine put to final test in thousands of volunteers

Southwest Life

Virus vaccine put to final test in thousands of volunteers

Vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The world’s biggest COVID-19 vaccine test got underway Monday, July 27 with the first of 30,000 planned volunteers. The experimental vaccine is made by the National Institutes of Health and Moderna Inc., and it’s one of several candidates in the final stretch of the global vaccine race.
Neal Browning, the second person to receive a trial dose of a COVID-19 vaccine, poses for a photo holding a hummingbird feeder, Friday, July 24, 2020, in Bothell, Wash. As the world’s biggest COVID-19 vaccine study gets underway more than four months after Browning and 44 others became the first participants in a phase-one coronavirus vaccine study that has produced encouraging results, more than 150,000 Americans have filled out an online registry in recent weeks signaling interest to volunteer for other studies, according to a virologist with the Fred Hutchinson Cancer Research Institute in Seattle.

Virus vaccine put to final test in thousands of volunteers

Vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The world’s biggest COVID-19 vaccine test got underway Monday, July 27 with the first of 30,000 planned volunteers. The experimental vaccine is made by the National Institutes of Health and Moderna Inc., and it’s one of several candidates in the final stretch of the global vaccine race.
Neal Browning, the second person to receive a trial dose of a COVID-19 vaccine, poses for a photo holding a hummingbird feeder, Friday, July 24, 2020, in Bothell, Wash. As the world’s biggest COVID-19 vaccine study gets underway more than four months after Browning and 44 others became the first participants in a phase-one coronavirus vaccine study that has produced encouraging results, more than 150,000 Americans have filled out an online registry in recent weeks signaling interest to volunteer for other studies, according to a virologist with the Fred Hutchinson Cancer Research Institute in Seattle.